[ Price : $8.95]
Federal Register Notice: FDA will open a public docket to make available a report on the pediatric studies of sodium nitroprusside...[ Price : $8.95]
CDER and Duke University Office of Continuing Medical Education co-sponsor a three-day training course for clinical investigators ...[ Price : $8.95]
Ethicon recalls numerous lots of thrombin due to a manufacturing process deviation that may have led to decreased potency in some ...[ Price : $8.95]
The HHS Inspector General says FDA should seek legal authority to review manufacturer substantiation for dietary supplement struct...[ Price : $8.95]
Alere Inc. says it has agreed to FDA-requested tighter release specifications for the companys Triage meter-based products.[ Price : $8.95]
Mallinckrodt asks FDA to require specific bioequivalence measures for any generic form of its Exalgo.[ Price : $8.95]
An FDA-commissioned bioequivalence study of Tevas Budeprion XL 300mg ends six years of controversy over adverse effects in patient...[ Price : $8.95]
A new study says that pediatric drug exclusivity strategies can see a return-on-investment on average of $130 for every $1 spent.